Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Eli Lilly, the drugmaker with two weight-loss bestsellers, just got its first dose of healthy skeptism during a time when the ...

A biotech startup announced in February that the FDA had certified its daily pill as having a “reasonable expectation of ...

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The medication - and similar drugs - have been catapulted into the heart of pop ...

But these researchers are facing a mounting pile of challenges when it comes to conducting their clinical trials, partly because of increasingly stretched resources at study sites. Last year ...